Phramongkutklao Hospital

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon et al. · The Lancet Oncology · 2014 · 781 citations

Hematological Malignancy, Double-blind Phase 3, Medicine +9

Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

W. G. E. Cooksley, Teerha Piratvisuth, Shin‐Da Lee et al. · Journal of Viral Hepatitis · 2003 · 476 citations

Randomized phase III study 306

Gregory L. Krauss, José M. Serratosa, Vicente Villanueva et al. · Neurology · 2012 · 424 citations

Oral impacts affecting daily performance in a low dental disease Thai population

Supreda Adulyanon, Jinda Vourapukjaru, Aubrey Sheiham · Community Dentistry And Oral Epidemiology · 1996 · 367 citations